APOE and Alzheimer disease: Overall, after factoring multiple parameters such as the number of trained neurologists, AD affects the population of all countries at a similar rate [1], which hinders the pinpointing of discrete genetic or environmental risk and protective factors outside those already known, such as age and Apolipoprotein E (ApoE) allelic status.